The Phase I/II trial sought to establish the impact of DYNE-251 on mobility-related endpoints, seeing an increase over ...

AbbVie has reported analysis from a Phase III trial that assessed Elahere against chemotherapy for platinum-resistant ovarian ...

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAb in their systems.

Amgen’s Uplizna (inebilizumab-cdon) has shown sustained efficacy in a group of gMG patients after 52 weeks in a Phase III ...

On this World Tuberculosis Day, a renewed commitment must be made to reach all patients with TB and prevent the spread of disease. Credit: Andrew Angelov via Shutterstock. The international community ...

The company’s weight loss therapy was able to sustain itself for up to 40 days in obese patients after a single injection.

Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

Everest Medicines has dosed the first subject with EVM16, the company’s personalised mRNA cancer vaccine, in the EVM16CX01 ...

Merck’s lupus drug enpatoran has failed to meet the primary endpoint in a subgroup of patients, but the drug's development is ...

The US FDA has ordered BioNTech to immediately halt its Phase I/II trial of BNT165e, a malaria vaccine candidate, pending ...

Persica's antibiotic-based drug could benefit patients with chronic lower back pain who are suffering from an infection in ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.